CAR-T Cell Therapy in Myeloma

Current and Emerging CAR T-Cell Therapies for MyelomaПодробнее

Advice for Inquiring About Myeloma CAR T-Cell Therapy Clinical TrialsПодробнее

CAR T-Cell Therapy Support | Questions to Ask About the ProcessПодробнее

SESSION I - 12th International Conference "Complex treatment of plasma cell dyscrasias in 2024"Подробнее

Multiple Myeloma Treatment: Induction, CAR T, Managing Side Effects and Maintaining Quality of LifeПодробнее

Relapsed/refractory multiple myeloma (RRMM): Best practices in treating early RRMMПодробнее

Will CAR-T be best when used in early relapse in myeloma?Подробнее

What is Immunotherapy for Multiple Myeloma? Understanding Its Role in TreatmentПодробнее

Undergoing CAR T-Cell Therapy? Why Managing Overall Health Is EssentialПодробнее

Relapsed/refractory multiple myeloma (RRMM): Best practices in treating early RRMMПодробнее

CAR-T therapy for myeloma including Indian experienceПодробнее

Can stored stem cells be used after CAR T-cell therapy?Подробнее

Navigating CAR T-Cell Therapy: Jerry and Jill's Advice | Living Well with Multiple MyelomaПодробнее

Frontline and CAR-T Cell Therapy for Multiple Myeloma | Xavier Leleu, MD, MSc, PhD | EHA 2024Подробнее

Dr Hernandez-Ilizaliturri on the Use of CAR T-Cell Therapy in R/R Multiple MyelomaПодробнее

Dr Ignatz-Hoover on the Future of CAR T-Cell Therapy and Bispecific Antibodies in R/R MyelomaПодробнее

Current use of CAR T-cell therapies in clinical practice – Q&AПодробнее

Q&A | How to sequence CAR T-cell therapy and bispecific antibodies in R/R MMПодробнее

Current use of CAR T-cell therapies in clinical practiceПодробнее

CAR T cell therapy and infection prevention | Dana-Farber Cancer InstituteПодробнее